Laurion Capital Management’s Aceragen Inc ACGN Stock Holding History

Laurion Capital Management’s Portfolio ACGN Stock Details ACGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-2,925	Closed	-$596K	–	1629
2016 Q4	$596K	Buy	+2,925	New	+$698K	0.01%	806

Other funds holding ACGN

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Laurion Capital Management's ACGN Position: Q1 2017 in Review

Laurion Capital Management sold out of Aceragen Inc (ACGN) in Q1 2017, closing a stake of 2,925 shares — an estimated $596K sold.

Laurion Capital Management first reported a position in ACGN in Q4 2016 and held it in 1 quarter. The position peaked at $596K in Q4 2016. 82 funds tracked by Wall St. Rank hold ACGN as of Q1 2017.

Laurion Capital Management reported no remaining Aceragen Inc position as of Q1 2017 after selling out during the quarter.
Laurion Capital Management sold 2,925 Aceragen Inc shares in Q1 2017, an estimated $596K.
Laurion Capital Management first reported a position in Aceragen Inc in Q4 2016 and held it in 1 quarter.
Laurion Capital Management's Aceragen Inc position peaked at $596K in Q4 2016.
82 funds tracked by Wall St. Rank held Aceragen Inc as of Q1 2017.

Based on Laurion Capital Management's 13F filing for Q1 2017, filed 12 May 2017.